Diabetes

Treatment nearly doubled the risk of severe hypoglycemia that required medical attention in patients with type 2 diabetes.

This month, able-bodied Muslims around the world are fasting from dawn until dusk in observance of the holy month of Ramadan.

Varying treatments were seen among patients with diabetes, depression, and hypertension.

Metformin found to improve survival in breast cancer and shows promise in endometrial hyperplasia.

Insulin plus metformin was seen to lower the risk of death and major cardiac events in patients with type 2 diabetes.

Approximately 45% of female patients with atrial fibrillation did not receive blood thinning treatment to prevent strokes.

Study finds new technique may improve treatment of diabetes.

Study finds link between marital bliss and greater risk of diabetes development.

Linagliptin and metformin hydrochloride extended-release (Jentadueto XR) tablets approved for type 2 diabetes.

Linagliptin and metformin hydrochloride extended-release tablets approved for adults with type 2 diabetes.

The burden of repeated insulin injections is often cited as a factor of resistance to starting traditional insulin products.

The FDA has issued new guidance for the use of the first-line diabetes drug metformin in patients with renal impairment.

The FDA has approved linagliptin and metformin hydrochloride extended-release (Jentadueto XR) tablets for adults with type 2 diabetes.

Because diabetes can affect many parts of the body, there's a lot to remember for self-management.

Treatment delays prevent tight blood sugar control in type 2 diabetes patients.

Vegetative area levels linked to significant decreases in diabetes, chronic illnesses, high cholesterol, and hypertension.

Lixisenatide is an investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist for adults with type 2 diabetes.

Acute exenatide administration reduces glucose production and insulin resistance in liver tissue.

Important health screenings for patients taking antipsychotic medication are not being carried out in certain patient groups.

Patients who develop foot ulcers and necrosis as a result of their diabetes may be at risk of experiencing significant cognitive declination.

Potential risk of leg and foot amputations associated with the use of the diabetes medication canagliflozin.

Pharmacists can have a positive influence on medication adherence and several other factors in type 2 diabetes.

Diabetes drug interactions may decrease medication efficacy, increase toxicity, challenge adherence, and cause adverse events.

Patients with diabetes have a higher pill burden than the general population, so pharmacists should pay particular attention to potential drug interactions with antidiabetic agents.

Dendritic cell-based therapy shows promise treating diabetic peripheral neuropathy and ulcerations in the cornea and skin.